Cyclophosphamide pulse therapy for refractory rheumatic diseases

Japanese Journal of Clinical Immunology

Volumn 20, Issue 3, 1997, Pages 152-158

  Tateishi, Mutsuto ^a,b   Taniguchi, Atsuo ^a   Moriguchi, Masato ^a   Hara, Masako ^a   Kashiwazaki, Sadao ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION MURAYAMA MEDICAL CENTER   (Japan)

Author keywords

Autoimmune thrombocytopenia; CNS disturbance; Cyclophosphamide pulse therapy; Interstitial pneumonia; Vasculitis

Indexed keywords

CYCLOPHOSPHAMIDE;

ARTICLE; CASE REPORT; DERMATOMYOSITIS; DRUG ADMINISTRATION; FEMALE; HUMAN; MIDDLE AGED; POLYMYOSITIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARTHRITIS, RHEUMATOID; CYCLOPHOSPHAMIDE; DERMATOMYOSITIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POLYMYOSITIS; RHEUMATIC DISEASES;

EID: 0031154488     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.20.152     Document Type: Article

References (19)

1. Dinant, HJ., Decker, J.L., Klippel, J.H., et al.: Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis. Ann. Inter. Med., 96: 728–736, 1982.
2. McCune, W.J., Golvus, J., Zeldes, W., et al.: Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N. Eng. J. Med., 318: 1423–1431, 1988.
3. Berlanga, B., Rubio, F.R., Moga, I., et al.: Response to intravenous cyclophosphamide treatment in lupus myelopathy. J. Rheumatol., 19: 829–830, 1992.
4. Boumpas, D.T., Yamada, H., Patronas, N.J., et al.: Pulse cyclophosphamide for severe neuropsychiatric lupus. Quart. J. Med., 81(296): 975–984, 1991.
5. Boumpas, D.T., Barez, S., Klippel, J.H., et al.: Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus. Ann. Intern. Med., 112: 674, 1990.
6. Reiner, A., Gernsheimer, T., Slichter, S.J.: Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura. Blood, 85(2): 351–358, 1995.
7. Walport, M.J., Hubbard, W.N., Hughes, G.R. V., et al.: Reversal of aplastic anemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide. Br. Med. J., 285: 769, 1982.
8. Winkler, A., Jackson, R.W., Kay, D.S., et al.: High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia. Arthritis Rheum., 31: 693, 1988.
9. Eiser, A.R., Shanies, H.M.: Treatment of lupus interstitial lung disease with intravenous cyclophosphamide. Arthritis Rheum., 37(3): 428–431, 1994.
10. Haubitzs, M., Frei, U., Rother, U., et al.: Cyclophosphamide pulse therapy in Wegener’s granulomatosis. Nephrol. Dial. Transplant., 6(8): 531–535, 1991.
11. D.C., Hess, K., Sethi, E., Awad, Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: Effective treatment with plasma exchange and immunosupuression, J. Rheumatol., (1992), 19, 1474-1478
12. J.A., Rump, B., Lang, H., Engler, et al., Primary antiphospholipid syndrome (PAPS): Two case reports and therapeutic implications, Rheumatol. Int., (1991), 10, 255-260
13. S., De-Vita, V., Fossaluzza, Treatment of idiopathic inflammatory myopathies with cyclophosphamide pulses: Clinical experience and a review of the literature, Acta. Neurol. Belg., (1992), 92, 4, 215-227
14. Hirano, F., Tanaka, H., Nomura, Y., et al.: Successful treatment of refractory polymycsitis with pulse intravenous cyclophosphami de and low-dose weekly oral methotrexate therapy. Intern. Med., 32(9): 749–752, 1993.
15. Al-Janadi, M., Smith, CD., Karsh, J.: Cyclo phosphamide treatment of interstitial pulmo nary fibrosis in polymyositis/dermatomyositis. J. Rheumatol., 16: 1592–1596, 1989.
16. Hamza, M., Meddeb, S., Mili, I., et al.: Bulu of cyclophosphamide and methylprednisolone in uveitis in Behcet’s disease. Preliminary results with the use of new criteria of evaluation. Ann. Med. Interne Paris, 143: 438–441, 1992.
17. Arnold, M.H. et al: Prospective pilot study of intravenous pulse cyclophosphamide therapy for refractory rheumatoid arthritis [letter]. Arthritis Rheum., 32: 933–934, 1989.
18. Kashiwazaki, S., Tateishi, M. and Hara, M.: Cyclophosphamide pulse therapy for refractory rheumatic diseases. Annual report of the Ministry of the Health and Welfare. Autoimmune Disease Research Committee. 51–56, 1995.
19. G.S., Hoffman, et al., Wegener’s granulomatosis: An analysis of 158 patients, Ann Intern. Med., (1992), 116, 488-498